The Quebec pharmaceutical company is proud to announce the distribution of a second family of products in this major market
BLAINVILLE, QC, March 8, 2016 /CNW Telbec/ - On International Women's Day, Duchesnay Inc., a Canadian pharmaceutical company dedicated to the health and quality of life of the pregnant woman and her unborn child, proudly announces the launch of two new products in the American market, prenatal vitamins Mteryti® and Mteryti® Folic 5, sold by prescription in Canada under the brand name Pregvit® and Pregvit® Folic 5.
With plans to expand beyond Canadian borders, particularly in the U.S., Duchesnay has distinguished itself by responding to a growing global demand for high-quality products for pregnant women and women who are breastfeeding. Like Pregvit® and Pregvit® Folic 5, Mteryti® and Mteryti® Folic 5 prenatal multivitamins are developed and manufactured in Canada. They will be marketed by Duchesnay USA based in Philadelphia.
“Duchesnay has been marketing its products for the past three years in the U.S. and for over 40 years in Canada,” said Éric Gervais, Executive Vice-President at Duchesnay. “Adding the Mteryti® family to our American division’s portfolio that already includes Diclegis® (doxylamine succinate and pyridoxine hydrochloride) (Diclectin® in Canada) is in keeping with our unique mission.”
About Pregvit® and Pregvit® Folic 5
The prenatal multivitamins Pregvit® and Pregvit® Folic 5 offer a uniqueformulation and two-part dosage (a pink pill in the morning and a blue pill at night) meant to optimize the absorption of key nutrients during preconception, pregnancy and breastfeeding. The formulation reduces side effects such as gastrointestinal problems, nausea and constipation. Plus the formulation does not contain lactose, gluten or tartrazine. The product is also certified kosher/Passover and halal by recognized agencies.
Pregvit® Folic 5 was designed for women who have had a pregnancy with a neural tube anomaly, who have a family history of neural tube anomalies, who suffer from diabetes or malabsorption issues (e.g., inflammatory bowel disease), who take folic acid antagonists (e.g., methotrexate) or anticonvulsants (e.g., valproic acid, carbamazepine) or who need a high dose of folic acid according to the advice of their health care professional.
Pregvit® and Pregvit® Folic 5 are available by prescription only in Canada. Women who are planning to get pregnant should talk to their health care provider to determine which product best meets their health needs.
Duchesnay Inc. is a Canadian specialty pharmaceutical company dedicated to improve the health and quality of life of pregnant women by working at advancing maternal-fetal medicine to reduce the risk of birth defects and by developing safe and effective pharmacological solutions for use during pregnancy and breastfeeding. For more information, visit www.duchesnay.com.
SOURCE Duchesnay inc.
Image with caption: "Logo: Duchesnay inc. (CNW Group/Duchesnay inc.)". Image available at: http://photos.newswire.ca/images/download/20160308_C4701_PHOTO_EN_634825.jpg
For further information: Ron Vaillancourt, Communications Manager, Duchesnay, 1 877 833-7734, email@example.com; Alida Alepian, Senior Consultant, Capital-Image, 514 739-1188, ext. 239, aalepian@capital-Image.com